B-cell Malignancies Clinical Trials in Hefei, Anhui
2 recruitingHefei, Anhui, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
The LVIVO-TaVec100 Product in the Treatment of Relapsed/Refractory B-cell Malignancies
Relapsed/Refractory B-cell Malignancies
The First Affiliated Hospital with Nanjing Medical University30 enrolled6 locationsNCT07002112
Recruiting
Early Phase 1
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.
CD19-positive Relapsed or Refractory B-cell Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.10 enrolled1 locationNCT06092047